Form 4: Adverum Biotechnologies Investor Leonard Braden Michael Acquires Additional Shares
SEC Form 4 Filing
Braden Michael Leonard, a director and 10% owner of Adverum Biotechnologies, acquired 85,800 shares of common stock at $7.15 per share on July 30, 2024.
Summary
- On July 30, 2024, Braden Michael Leonard, a director and 10% owner of Adverum Biotechnologies, acquired 85,800 shares of common stock.
- The purchase price was $7.15 per share.
- Following the transaction, Leonard directly owns 104,800 shares and indirectly owns 2,268,064 shares through BML Investment Partners, L.P.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed favorably, but the document itself is simply a regulatory filing.
Positives
- A director and significant shareholder increasing their stake in the company can be seen as a positive signal.
Industry Context
Insider buying is often viewed as a positive sign, suggesting that those with the most knowledge of the company's prospects are optimistic about its future.
Stakeholder Impact
- The purchase could increase investor confidence in Adverum Biotechnologies.
Key Dates
| Date | Description |
|---|---|
| 07/30/2024 | Date of transaction: Purchase of 85,800 shares of common stock. |
| 07/31/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.